← SynDRA
BRD-K95676198
SynDRA canonical compound SYN0062674 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | JAK3 |
| Mechanism of action | JAK inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- JAK3-inhibitor-V
- Thr1 inhibitor, 1
- RefChem:1100093
- ZM 449829
- 1-(naphthalen-2-yl)prop-2-en-1-one
- 1-naphthalen-2-ylprop-2-en-1-one
- 1-(2-Naphthalenyl)-2-propen-1-one
- 1-(2-naphthyl)prop-2-en-1-one
- MFCD04974535
- 2-acryloylnaphthalene
- ZM449829
- 1-(2-Naphthyl)-2-propen-1-one
- 2-naphthyl vinyl ketone
- Bedaquiline Impurity 55
- BiomolKI_000064
- BiomolKI2_000005
- BMK1-G4
- SCHEMBL149980
- orb1703889
- SCHEMBL13158925
- SCHEMBL29707545
- SCHEMBL30827199
- BDBM85122
- CHEBI:93674
- FOTCGZPFSUWZBN-UHFFFAOYSA-N
- HMS3412I18
- HMS3676I18
- EX-A10475
- HSCI1_000051
- AKOS006293213
- CCG-100668
- NCGC00092279-01
- NCGC00092279-02
- NCGC00092279-03
- BS-16843
- HY-13450
- SY045948
- DB-082069
- CS-0006905
Look up BRD-K95676198 in the interactive SynDRA portal →